secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001534969-24-000084
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q1 net loss narrows to $8.1M; net revenue nil after adjustments
--------------------------------------------------------------------------------

- Net revenue nil after periodic review of accounting estimates for older tests; gross revenue $39K vs $100K YoY.
- Net loss $8.1M, improved 24% from $10.6M loss in Q1 2023.
- Operating expenses $9.1M, down 20% YoY; SG&A $5.4M (-26%), R&D $3.7M (-10%).
- Shipped first ambient whole blood collection kits to reduce COGS and expand access.
- Submitted PRIME study interim analysis manuscript for peer-reviewed publication.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496924000084/0001534969-24-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496924000084/sera-20240508.htm
  HTML page:      https://secwatch.observer/filing/0001534969-24-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer